-
2024-516100-42-00
4
2022-03-18
Melanoma
-
2023-510088-37-00
5
2022-03-15
Acyclovir-resistant mucocutaneous HSV infections in immunocompromised
-
2024-516021-32-00
5
2022-02-17
Critically ill patients suffering from CIRCI
-
2024-513030-38-00
5
2022-02-15
Invasive fungal infections due to Aspergillus spp.
-
2023-508820-37-00
5
2022-02-03
Cytomegalovirus Infection (CMV)
-
2024-515071-35-00
6
2022-01-06
Somatostatin Receptor Positive Neuroendocrine Tumours (NETs)
-
2023-506117-22-00
3
2022-01-05
Acute Myeloid Leukemia and Myelodysplastic Syndromes
-
2024-513532-23-00
5
2021-12-06
early syphilis
-
2023-507688-20-00
5
2021-12-03
Participants with completely resected Stage III or Stage IV melanoma
-
2024-512945-18-00
5
2021-11-30
Geographic Atrophy Secondary to Age-Related Macular Degeneration
-
2023-509196-16-00
6
2021-11-19
Upper limb spasticity (ULS) of any aetiology (in US and France) or pos
-
2024-517549-15-00
5
2021-11-16
Resistant Depression in the Elderly Subject
-
2024-514934-19-00
5
2021-11-08
Post-surgical neuropathic pain
-
2024-517241-13-00
4
2021-10-22
metastatic colorectal cancer
-
2024-510744-31-00
5
2021-10-06
Giant cell arteritis (GCA)
-
2023-510046-25-00
7
2021-09-02
Soild Tumors
-
2024-511158-36-00
9
2021-08-05
Metastatic colorectal cancer
-
2024-516577-76-00
8
2021-06-28
Kidney transplant
-
2024-515353-24-00
4
2021-06-22
Patients with high risk myelodysplastic syndrome or acute myeloid leuk
-
2023-507497-40-00
1
2021-05-31
Diffuse large B-cell lymphoma (DLBCL), Grade 3B follicular lymphoma, H
-
2024-514990-23-00
9
2021-03-31
Cancer
-
2023-508301-25-00
4
2021-03-26
Relapse/Refractory Lymphomas
-
2023-504834-23-00
11
2021-02-24
Advanced/Metastatic Gastroesophageal Adenocarcinoma
-
2024-514344-82-00
5
2021-02-18
patients with acute respiratory failure from undetermined etiology